Home / Resource Library / UPDATED TRENDS IN REAL-WORLD OUTPATIENT (OP) ADMINISTRATION OF AXICABTAGENE CILOLEUCEL (AXI-CEL) AND BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) IN RELAPSED/REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL)

UPDATED TRENDS IN REAL-WORLD OUTPATIENT (OP) ADMINISTRATION OF AXICABTAGENE CILOLEUCEL (AXI-CEL) AND BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) IN RELAPSED/REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL)

EHA 2024

Membership Organisation

Healthcare Professional

Affected by Lymphoma

Researcher or Advocate

UPDATED TRENDS IN REAL-WORLD OUTPATIENT (OP) ADMINISTRATION OF AXICABTAGENE CILOLEUCEL (AXI-CEL) AND BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) IN RELAPSED/REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL)